Adjunctive therapy

Details Adjunctive therapy Adjunctive therapy

1996-03-18

1997-11-25

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514800, A61K 3809

Patent

active

056913141

ABSTRACT:
A growth such as a tumor, hypertrophied tissue or cyst is biopsied or more completely excised subsequent to the administration of an effective amount of a gonadotropin releasing hormone analog or other inhibitor of ovarian steroid production or action.

REFERENCES:
Lumsden et al. Treatment With the Gonadotropin Releasing Hormone-Agonist Goserelin. Brit. J. of Obstet. and Gyn. 1994. vol. 101, pp. 438-442.
Audebert et al. Deferred Versus Immediate Surgery For Uterine Fibroids. Brit. J. of Obstet. and Gyn. 1994. vol. 101, Suppl. 10, pp. 29-32.
Stovall et al. GnRH Agonist. Obstetrics and Gynecology. 1995, vol. 86, No. 1, pp. 65-71.
Soloway et al. Randomized Prospective Study. J. of Urol. 1995. vol. 154, pp. 424-428.
Perry et al. Goserelin. Drugs. 1996. vol. 51, No. 2, pp. 319-346.
Hellstrom et. al. A 3-Year Follow-Up of Patients. Brit. J. of. Urol. 1996. vol. 78, pp. 432-436.

Affiliated with

Also associated with

Rating

Adjunctive therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjunctive therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjunctive therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2107167